AHD-RESEARCH-001 — Research Status (UPDATED 24/04/2026)
Avina Home Detox LLC Status: ALL 5 SEATS LANDED — synthesis complete Started / Completed: 24/04/2026
Status: COMPLETE
All 5 NEXUS swarm seats have returned. Total research time: ~5-9 minutes per seat in parallel. Token cost: ~$3-5 USD across all seats vs ~$50-200 if attempted inline on Opus.
| Seat | Topic | Status | Key Finding |
|---|---|---|---|
| 01 | NAD IV clinical evidence | LANDED | No RCTs in AUD/OUD; pilot data only; specific defensible vs avoid claims defined |
| 02 | Concierge IV competitive landscape | LANDED | White space confirmed; AHD position is unoccupied; pricing benchmarks verified |
| 03 | In-home IV regulatory map CA/NY/FL | LANDED | 5 critical landmines identified including AB5, HHA licensure, controlled substance chain of custody |
| 04 | Combined detox + IV protocol design | LANDED | 8-protocol IV library v1.0 with evidence grades; replaces v0.1 placeholder |
| 05 | UHNW concierge wellness brand teardown | LANDED | 3 brand directions for AHD; Swiss transparency vs opacity model analysis; voice cues |
Where to Read
The synthesis: AHD-RESEARCH-SYNTHESIS-v1.0.md — the boardroom-ready synthesis of all 5 returns with action items per finding.
Critical headlines from the synthesis:
- CA AB5 likely makes the 1099 nurse model illegal. Cost basis shifts.
- HHA licensure required in all 3 states. Adds $30K + 60-120 days per state.
- NAD has no RCT evidence. Marketing claims must be carefully scoped.
- White space is confirmed. No US competitor sits at AHD’s exact intersection.
- CA-only Y1 launch is the correct strategy given the regulatory stack.
Documents that need v0.2 update based on the findings
- AHD-CAPITAL-PLAN-v0.1 → v1.0 (cost basis revision)
- AHD-REGULATORY-MAP-v0.1 → v1.0 (replace placeholder with 5-landmine framework)
- AHD-IV-LIBRARY-v0.1 → v1.0 (8 evidence-graded protocols)
- AHD-BRAND-DIRECTION-v0.1 → v1.0 (3 brand directions)
- AHD-OPERATING-MANUAL-v0.1 (controlled-substance handling section)
- AHD-NURSING-CURRICULUM-v0.1 (Module 07 IV Library reference)
- Marketing site (site/index.html) — NAD claims + brand voice
- AHD-COUNSEL-SHORTLIST briefing — expanded scope for Nelson Hardiman
These updates are queued. The synthesis document captures all the changes in one place; individual document updates can be sequenced based on what Fabian wants to walk first.
Status: ALL LANDED · Synthesis complete · Awaiting Fabian’s decision on the 5 forced decisions in the synthesis (nurse classification, capital revision, brand direction, NAD claims discipline, multi-state strategy).